Business analytics and healthcare: An interview with Opher Baron

graphic representing business analytics

Opher Baron is Distinguished Professor of Operations Management at the Rotman School of Management, University of Toronto. His research interests are broad and varied, covering everything from business analytics in relation to healthcare, to autonomous vehicles. Recently, his work has had huge practical impact, as he and his colleagues Professor Philipp Afèche, Ming Hu, and Dmitry Krass launched the COVID PPE Help platform, a service which has facilitated the […]

Read More… from Business analytics and healthcare: An interview with Opher Baron

MicroRNAs as promising biomarkers and therapeutic tools in hereditary hemorrhagic telangiectasia

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder that results in potentially fatal blood vessel abnormalities. Currently, there is no cure or universally effective treatment for the condition, which remains underfunded and underdiagnosed. MicroRNAs have emerged as new biomarkers for human diseases and hold great promise for the improved diagnosis and treatment of HHT. A recent review publication by Anthony […]

Read More… from MicroRNAs as promising biomarkers and therapeutic tools in hereditary hemorrhagic telangiectasia

Off-the-shelf immunotherapy could lead to more accessible cancer treatment

Off-the-shelf immunotherapy could lead to more accessible cancer treatmen

Immunotherapy is a type of cancer treatment that harnesses the immune system to destroy cancerous cells. Dr Li Zhang and colleagues at Toronto General Hospital Research Institute and the University of Toronto, are pioneering a new type of “off-the-shelf” treatment using a type of immune cell—a double negative T (DNT) cell. Dr Zhang‘s work shows that DNT cells are a […]

Read More… from Off-the-shelf immunotherapy could lead to more accessible cancer treatment

Helping patients put their best foot forward

Dr Hawker researches osteoarthritis (OA) outcomes. A predominant theme of her work is the appropriate use of hip and knee joint replacement surgery for OA.

Dr Gillian Hawker of the University of Toronto is helping potential knee replacement patients to make informed decisions about their health. As an increasing number of us require joint replacement, Dr Hawker seeks to make sure that only those who are best suited will undergo surgery. By developing standardised patient assessment criteria for knee surgery, Dr Hawker is striving to […]

Read More… from Helping patients put their best foot forward